ISO 11135 PDF


ISO (E). PDF disclaimer. This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file. ISO. Second edition. Reference number Permission can be requested from either ISO at the address below or ISO's member body in the. ISO specifies requirements for the development, validation and routine control of an ethylene oxide sterilization process for medical devices in both.

Iso 11135 Pdf

Language:English, German, Arabic
Genre:Politics & Laws
Published (Last):31.08.2016
ePub File Size:25.83 MB
PDF File Size:15.81 MB
Distribution:Free* [*Sign up for free]
Uploaded by: ROCCO

(Combined revision of ANSI/AAMI/ISO and ANSI/AAMI/ISO TIR). Sterilization PREVIEW. ANSI/AAMI/ISO “Sterilization of health care products – Ethylene oxide -. Part 1: Requirements for the development, validation and routine control . ISO. First edition. Corrected version Details of the software products used to create this PDF file can be found in the General Info relative.

July Sterilization of health-care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices. November Sterilization of health-care products - Ethylene oxide - Requirements for the development, validation and routine control of a sterilization process for medical devices Adopted ISO July Sterilization of health-care products.

Ethylene oxide. Requirements for the development, validation and routine control of a sterilization process for medical devices. Sterilization of health-care products. July Sterilization of health care products. Guidance on the application of ISO June Sterilization of health care products. D provides explanations and methods that are regarded as being suitable means for complying with the requirements for industry and health care facilities.

The guidance, in Annex?

D, is intended for people who have a basic knowledge of the principles of EO sterilization. Methods other than those given in the guidance can be used if they are effective in achieving compliance with the requirements of ISO?

The development, validation and routine control of a sterilization process comprises a number of discrete but interrelated activities; e. While the activities required by ISO? The activities required are not necessarily sequential, as the programme of development and validation may be iterative. This International Standard does not specify the particular individuals or organizations to carry out the activities.

You might also like: NTC ISO 14004 PDF DOWNLOAD

It is important that patient safety be addressed by minimizing exposure to EO and its by-products during normal product use. The major differences relate to the unique physical and organizational conditions in health care facilities, and to the initial condition of reusable medical devices being presented for sterilization. The primary function of the health care facility is to provide patient care; medical device reprocessing is just one of a myriad of activities that are performed to support that function.

Irish Standard I.S. EN ISO 11135:2014

Health care facilities, on the other hand, must handle and process both new medical devices and reusable medical devices of different descriptions and with varying levels of bioburden. They are therefore faced with the additional challenges of cleaning, evaluating, preparing and packaging a medical device prior to sterilization.

In this International Standard, alternative approaches and guidance specific to health care facilities are identified as such. Specific recommendations have been produced in particular countries for the processing of materials potentially contaminated with these agents. NOTE 1. See for example EN? See ISO? NOTE The effective implementation of defined and documented procedures is necessary for the development, validation and routine control of a sterilization process for medical devices.

Such procedures are commonly considered to be elements of a quality management system. It is not a requirement of this International Standard to have a full quality management system during manufacture or reprocessing.

The necessary elements are normatively referenced at appropriate places in the text see, in particular, Clause? Attention is drawn to the standards for quality management systems see ISO?

Standard Subscriptions

National or regional regulations may also exist. Attention is drawn to the possible existence in some countries of regulations giving safety requirements for handling EO and for premises in which it is used. For further information see ISO?

For dated references, only the edition cited applies. For undated references, the latest edition of the referenced document including any amendments applies. Ethylene oxide sterilization residuals ISO? General requirements ISO? Biological indicators for ethylene oxide sterilization processes ISO? Tests of sterility performed in the definition, validation and maintenance of a sterilization process ISO?

This part of the sterilization cycle can be carried out either at atmospheric pressure or under vacuum. See 3. For the purposes of this International Standard, the D value is the exposure time required to achieve 90?

Any cooling of the atmosphere below the dew point would produce water condensation. For the purpose of calculation of cycle lethality, it is the period of sterilization between the end of EO injection and the beginning of EO removal. This method of process release does not include the use of biological indicators. An external PCD is an item designed to be used for microbiological monitoring of routine production cycles.

For the purpose of this International Standard, a PCD can be product, simulated product or other device that is inoculated directly or indirectly. See 7. The specification for a sterilization process includes the process parameters and their tolerances. All products within the category have been determined to present an equal or lesser challenge to the sterilization process than the process challenge device for that group. For the purposes of sterilization standards, product is tangible and can be raw material s , intermediate s , sub-assembly ies and health care products.

This is not a medical device that is designated or intended by the manufacturer for single use only. Describing the reduction in the number of spores on a biological indicator or inoculated item produced by exposure to specified conditions. For Direct Enumeration: N0 Nu is the initial population; is the final population. N0 q n is the initial population; If there are no survivors, the true SLR cannot be calculated.

In practice, no such absolute statement regarding the absence of microorganisms can be proven. The term SAL takes a quantitative value, generally or When applying this quantitative value to assurance of sterility, an SAL of has a lower value but provides a greater assurance of sterility than an SAL of In a sterilization process, the nature of microbial inactivation is exponential and thus the survival of a microorganism on an individual item can be expressed in terms of probability.

While this probability can be reduced to a very low number, it can never be reduced to zero. This series of actions or operations includes preconditioning if necessary , exposure to the ethylene oxide under defined conditions and any necessary post-treatment required for the removal of ethylene oxide and its by-products. It does not include any cleaning, disinfection or packaging operations that precede the sterilization process.

The volume allowed for gas circulation around the load inside the chamber is not included as usable space. Documents and records shall be controlled in accordance with the applicable clauses of ISO?

Responsibility shall be assigned to competent personnel in accordance with the applicable clauses of ISO? These procedures shall comply with the applicable clauses of ISO?

This activity may be undertaken in a test or prototype system. Where this occurs, the final equipment specification see 6. For the purposes of this International Standard, the sterilizing agent is EO.

This literature provides knowledge of the manner in which the process variables affect microbial inactivation.

Reference to these general studies on microbial inactivation is not required by this International Standard. This International Standard does not require the performance of specific studies on material effects, but does require performance of studies of the effects of EO on product see Clause?

Measures necessary to protect the health and safety of personnel shall be identified. This assessment, including potential impact and measures for control, shall be documented. NOTE In aeration these parameters are considered process variables only if aeration is considered to contribute to ensuring the microbicidal effectiveness of the sterilization process See AAMI?

This specification shall include: NOTE Some aspects of the equipment design may be influenced by national or regional regulatory requirements or standards. NOTE 6. NOTE This may be achieved either by the use of independent systems for control and monitoring or by a cross-check between control and monitoring which identifies any discrepancies or indicates a fault.

A demonstration of equivalence with reference to the challenge to the sterilization process to a previously validated product, package or loading configuration shall be considered to meet the requirement to perform product definition.

Any demonstration of equivalence shall be documented. This can be achieved by performing process definition and validation of a new product; or through the demonstration of equivalence to a previously validated product, or internal process challenge device internal PCD used to qualify the product SAL when exposed to the specified sterilization process See 8. NOTE 7. Design control is one aspect addressed in ISO? For reusable medical devices, an assessment of the effectiveness of the specified cleaning process and, if applicable, disinfecting process, shall be performed.

Information for the assessment of the effectiveness of cleaning and disinfection processes is given in the applicable parts of ISO? The defined product includes new or modified product, packaging or loading configurations. A or B or by an alternative method that demonstrates the product has achieved the required sterility assurance level SAL. The PCD shall present a challenge to the sterilization process that is equivalent or greater than the challenge presented by the natural bioburden at the most difficult to sterilize location within the product.

NOTE 8. Chemical indicators shall not be used as the sole means of establishing the sterilization process and shall not be used as an indicator that the required SAL has been achieved. For information on the selection, use and interpretation of biological indicators, see ISO?

Validation consists of a number of identified stages: IQ and OQ may be a one-time exercise for the specific equipment being employed for a sterilization process. These operating procedures shall include, but are not limited to b fault conditions, the manner in which they are indicated, and actions to be taken, c instructions for maintenance and calibration, and d details of contacts for technical support. The installation shall comply with all pertinent national, regional and local regulations.

NOTE If saleable product has been used during validation, 7. It shall be demonstrated that all product exposed to a sterilization process achieves the required SAL. Studies shall be performed in the production chamber using defined process parameters selected to deliver less lethality than the specified sterilization process.

A or Annex? B or by an alternative method that demonstrates achievement of the required product SAL. However, all internal PCDs should test negative.

If a failure can be attributed to factors not relevant to the effectiveness of the process being validated, this may be documented as unrelated to the performance of the process without requiring three further consecutive successful runs. Examples of this type of failure may include, but are not limited to, power failures, other loss of services, or failure of external monitoring equipment. If parametric release is to be used, also see 9. The results of this review shall be recorded.

The report shall be reviewed and approved by the designated responsible person s. NOTE For practical purposes, rates can be determined as the time taken with tolerances to attain a specified pressure change. P or terminal pressure and rate? The sampling shall be conducted at defined intervals sufficient to verify the required conditions throughout EO exposure.

This process specification shall also include the criteria for designating EO processed product as conforming product and approved for release. ISO These data shall include at least the following: ISO — All rights reserved Chemical indicators shall not replace biological indicators for product release or be used to support a rationale to release a load parametrically.

The criteria shall include: NOTE Formal release of the load from sterilization could require results from other tests e. EO residuals, endotoxin, physical testing, etc. If repair or alteration to the equipment is required, the necessary qualification shall be performed before this process can be used again. In the event of a positive BI, it is not acceptable to release product based on acceptable results of a product test for sterility. The non-conformity shall be addressed per documented procedures.

If saleable product is used in MPQ studies, then procedures shall be established to ensure the product is subjected to a full exposure sterilization process and formal review of its acceptance prior to release to market. E for information about single lot release. This shall include an assessment of the need to reconfirm the product SAL through microbiological studies.

The outcome of this review, including the rationale for decisions reached, shall be documented. These intervals shall be justified. As part of the investigation, the effect on the achievement of the specified SAL for previously processed loads of product shall be considered and a risk assessment undertaken on their suitability for use. The investigation and subsequent actions shall be recorded. The rationale for this reduced qualification shall be recorded and documented.

The influence of different geographical locations on the product or load properties shall be determined. A technical review shall be performed comparing the candidate product with the product or PCD that was used to validate the existing EO process. The outcome of the technical review, including the rationale for decisions reached, shall be documented.

The requirements of 7. Determination of lethal rate of the sterilization process? A normative A. Use of the method requires that product bioburden levels shall be demonstrated to be relatively consistent over time and the resistance of the bioburden be shown to be equal to, or less resistant than the resistance of the biological indicator see D. The resistance of the internal PCD is demonstrated by running the sterilization cycle at graded exposure times, or by exposing graded BI populations to a single sterilization exposure time, and then determining the lethal rate rate of inactivation through D-value calculations when exposed to the sterilization cycle.

EN & ISO standards (pdf)

Knowledge of the BI lethality rate and the population and relative resistance of the bioburden allows one to establish exposure time so that an SAL can be predicted. Guidance on this approach can be found in ISO? The incubation period shall take into account the possibility of delayed outgrowth of spores that have been exposed to EO. Refer to ISO? Conservative determination of lethal rate of the sterilization process?

B normative B. Sterilization processes qualified in this manner are often conservative and use a treatment that may exceed that required to achieve the specified requirements for sterility. The specified exposure time for the sterilization process shall be at least double this minimum time. A fractional cycle of short duration from which BI survivors can be recovered shall also be run to demonstrate the adequacy of the recovery technique for BIs exposed to EO gas.

Further guidance on the biological indicator incubation times can be found in ISO? The routine processing parameters that deliver minimally a 12 SLR of the biological indicator shall be established using one of the methods described in A.

The number of cycles is dictated by the method used.

If the location s of the microbiological challenge is other than the most difficult-to-sterilize within the product, its relationship to the most difficult location s shall be established. Attention must be given to the impact of packaging and the removal of sterilant from the PCD. Temperature sensors, RH sensors and biological indicator numbers Annex?

ISO 11135-1 and ISO/TS 11135-2 - HISTORICAL PACKAGE

C informative C. Therefore, monitoring should include more than one plane and locations near doors. For PQ, one temperature sensor is required per cubic metre of product volume. The minimum number of temperature sensors is three. For PQ, humidity sensors should be placed within the packaging where possible within the load. This can be achieved by placing the sensor within the sterile barrier system or amongst the unit packages.

The result of the calculation should be rounded to the next higher number. The number of sensors to use is at least three the minimum number of sensors to use. During OQ of a preconditioning room with a usable chamber volume of 70? The minimum number of sensors is two. The number of sensors to use is at 40 40 C. The number of sensors to use is at least For routine control: The number of BIs is at least five.

The number of BIs is at least Guidance on the application of the normative requirements The guidance given in this annex is not intended as a checklist for assessing compliance with this International Standard.

This guidance is intended to assist in obtaining a uniform understanding and implementation of this International Standard by providing explanations and acceptable methods for achieving compliance with specified requirements.

Methods other than those given in the guidance can be used, providing their performance achieves compliance with this International Standard NOTE For ease of reference, the numbering of clauses in this annex corresponds to that in the normative parts of this International Standard. D informative D.

In ISO? Each organization should establish procedures for identifying training needs and ensure that all personnel are trained to adequately perform their assigned responsibilities. This is especially important where contractors are engaged to carry out specific functions. Even where elements of the sterilization process are contracted out it is important to note that the medical device manufacturer is ultimately responsible for validation, release and distribution of sterilized product to the market.

In particular, it should be noted that the requirements in ISO? downloading procedures in a health care facility should ensure that reusable medical devices are supplied with validated instructions for cleaning, disinfection, sterilization and aeration as specified in ISO?

Downloads Medistri ; Downloads Overview Standards. Requirements for development, validation and routine monitoring of all sterilization processes. EO processes. ISO ; Nov 15, Details of the software products used to create this PDF file can be ISO and ISO describe the qualification process for an overkill method as follows: This method involves determination The shelf life of sterile medical devices ; the ISO codes on sterilisation a similar distinction is made between two different List of International Organization for Standardization Please consider splitting content into sub-articles, condensing it, or adding or removing subheadings.A fractional cycle of short duration from which BI survivors can be recovered shall also be run to demonstrate the adequacy of the recovery technique for BIs exposed to EO gas.

What are the new requirements for validation, requalification, equivalence assessment, monitoring and release? For health care facilities, excessive moisture content can also be caused by inadequate drying after cleaning. The temperature and humidity profile within the sterilization load should be evaluated during the time that is needed for the sterilization load to attain the minimum predetermined temperature and humidity.

P and rate? The outcome of the technical review, including the rationale for decisions reached, shall be documented. The rationale for this decision should be made by a sterilization specialist and should be documented.